PL379448A1 - Sposób wytwarzania preparatu zawierającego substancję aktywną w mikrodawce - Google Patents
Sposób wytwarzania preparatu zawierającego substancję aktywną w mikrodawceInfo
- Publication number
- PL379448A1 PL379448A1 PL379448A PL37944804A PL379448A1 PL 379448 A1 PL379448 A1 PL 379448A1 PL 379448 A PL379448 A PL 379448A PL 37944804 A PL37944804 A PL 37944804A PL 379448 A1 PL379448 A1 PL 379448A1
- Authority
- PL
- Poland
- Prior art keywords
- preparing
- formulation containing
- active principle
- microdosed
- microdosed active
- Prior art date
Links
- 238000009472 formulation Methods 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5015—Organic compounds, e.g. fats, sugars
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
- A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5089—Processes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Nutrition Science (AREA)
- Dermatology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Rheumatology (AREA)
- Diabetes (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Cosmetics (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Application Of Or Painting With Fluid Materials (AREA)
- Pretreatment Of Seeds And Plants (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0305684A FR2854802B1 (fr) | 2003-05-12 | 2003-05-12 | Procede de preparation d'une formulation contenant un principe actif microdose |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| PL379448A1 true PL379448A1 (pl) | 2006-09-18 |
| PL213809B1 PL213809B1 (pl) | 2013-05-31 |
Family
ID=33306296
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL379448A PL213809B1 (pl) | 2003-05-12 | 2004-05-07 | Sposób wytwarzania zasadniczo homogenicznej formulacji jako masci w mikrodawce |
Country Status (16)
| Country | Link |
|---|---|
| US (2) | US20060115501A1 (pl) |
| EP (1) | EP1624856B1 (pl) |
| JP (1) | JP4865560B2 (pl) |
| KR (1) | KR101125503B1 (pl) |
| CN (1) | CN100411608C (pl) |
| AR (1) | AR044289A1 (pl) |
| AU (1) | AU2004237995B2 (pl) |
| BR (1) | BRPI0409051A (pl) |
| CA (1) | CA2524228A1 (pl) |
| ES (1) | ES2533542T3 (pl) |
| FR (1) | FR2854802B1 (pl) |
| MX (1) | MXPA05011836A (pl) |
| PL (1) | PL213809B1 (pl) |
| RU (1) | RU2349303C2 (pl) |
| WO (1) | WO2004100924A2 (pl) |
| ZA (1) | ZA200508282B (pl) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN116531315B (zh) * | 2023-03-22 | 2024-02-13 | 江苏知原药业股份有限公司 | 一种卡泊三醇软膏及其制备方法 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS56140915A (en) * | 1980-04-07 | 1981-11-04 | Yamanouchi Pharmaceut Co Ltd | Pharmaceutical preparation for solid drug |
| AT370721B (de) * | 1981-02-24 | 1983-04-25 | Ciba Geigy Ag | Verfahren zur herstellung von neuen salzen der 2- (2,6-dichloranilino)-phenylessigsaeure, der |
| FR2515035A1 (fr) * | 1981-10-26 | 1983-04-29 | Rhone Poulenc Sante | Nouvelle forme galenique solide pour administration par voie orale et son procede de fabrication |
| US4610978A (en) * | 1983-03-22 | 1986-09-09 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Compositions containing 1α-hydroxycholecalciferol for topical treatment of skin disorders and methods employing same |
| CN1014867B (zh) * | 1987-07-29 | 1991-11-27 | 中山大学 | 分层包衣的微胶囊工艺 |
| JP3137821B2 (ja) * | 1994-01-07 | 2001-02-26 | 帝人株式会社 | 安定性の向上した乾癬治療用製剤 |
| JP3506474B2 (ja) * | 1994-01-07 | 2004-03-15 | 帝人株式会社 | 安定性の向上した乾癬治療剤 |
| AU2588297A (en) * | 1996-04-04 | 1997-10-29 | Ortho Pharmaceutical Corporation | Liposome-based topical vitamin d formulation |
| JP4729149B2 (ja) * | 1997-06-25 | 2011-07-20 | 帝國製薬株式会社 | 安定なアスピリン軟膏製剤 |
| US6274169B1 (en) * | 1999-08-02 | 2001-08-14 | Abbott Laboratories | Low oxygen content compostions of 1α, 25-dihydroxycholecalciferol |
| WO2002034235A1 (en) * | 2000-10-27 | 2002-05-02 | Leo Pharma A/S | Topical composition containing at least one vitamin d or one vitamin d analogue and at least one corticosteroid |
| JP2002321779A (ja) * | 2001-04-20 | 2002-11-05 | Daizo:Kk | 薬剤の微量拡散方法および微量拡散装置 |
-
2003
- 2003-05-12 FR FR0305684A patent/FR2854802B1/fr not_active Expired - Fee Related
-
2004
- 2004-05-07 PL PL379448A patent/PL213809B1/pl unknown
- 2004-05-07 RU RU2005138504/15A patent/RU2349303C2/ru not_active IP Right Cessation
- 2004-05-07 MX MXPA05011836A patent/MXPA05011836A/es active IP Right Grant
- 2004-05-07 AU AU2004237995A patent/AU2004237995B2/en not_active Ceased
- 2004-05-07 CN CNB2004800130086A patent/CN100411608C/zh not_active Expired - Fee Related
- 2004-05-07 BR BRPI0409051-9A patent/BRPI0409051A/pt not_active Application Discontinuation
- 2004-05-07 ES ES04742674.7T patent/ES2533542T3/es not_active Expired - Lifetime
- 2004-05-07 WO PCT/FR2004/001116 patent/WO2004100924A2/fr not_active Ceased
- 2004-05-07 EP EP04742674.7A patent/EP1624856B1/fr not_active Expired - Lifetime
- 2004-05-07 JP JP2006530335A patent/JP4865560B2/ja not_active Expired - Fee Related
- 2004-05-07 CA CA002524228A patent/CA2524228A1/fr not_active Abandoned
- 2004-05-07 KR KR1020057021140A patent/KR101125503B1/ko not_active Expired - Fee Related
- 2004-05-11 AR ARP040101593A patent/AR044289A1/es not_active Application Discontinuation
-
2005
- 2005-10-13 ZA ZA200508282A patent/ZA200508282B/xx unknown
- 2005-11-09 US US11/269,854 patent/US20060115501A1/en not_active Abandoned
-
2007
- 2007-05-04 US US11/797,634 patent/US7749986B2/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| ES2533542T3 (es) | 2015-04-10 |
| ZA200508282B (en) | 2006-09-27 |
| CN100411608C (zh) | 2008-08-20 |
| FR2854802B1 (fr) | 2005-06-24 |
| AU2004237995B2 (en) | 2010-11-04 |
| AU2004237995A1 (en) | 2004-11-25 |
| JP4865560B2 (ja) | 2012-02-01 |
| KR101125503B1 (ko) | 2012-03-21 |
| US20070249570A1 (en) | 2007-10-25 |
| BRPI0409051A (pt) | 2006-03-28 |
| MXPA05011836A (es) | 2006-01-26 |
| PL213809B1 (pl) | 2013-05-31 |
| FR2854802A1 (fr) | 2004-11-19 |
| WO2004100924A2 (fr) | 2004-11-25 |
| WO2004100924A3 (fr) | 2005-09-15 |
| AR044289A1 (es) | 2005-09-07 |
| CN1787807A (zh) | 2006-06-14 |
| CA2524228A1 (fr) | 2004-11-25 |
| JP2006528674A (ja) | 2006-12-21 |
| US20060115501A1 (en) | 2006-06-01 |
| RU2005138504A (ru) | 2006-07-27 |
| RU2349303C2 (ru) | 2009-03-20 |
| KR20060011992A (ko) | 2006-02-06 |
| EP1624856A2 (fr) | 2006-02-15 |
| HK1091120A1 (zh) | 2007-01-12 |
| US7749986B2 (en) | 2010-07-06 |
| EP1624856B1 (fr) | 2015-01-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1471955A4 (en) | AEROSOL GENERATOR FOR A MEDICINAL FORMULATION | |
| IL229510A0 (en) | A dosage form containing pantoprazole as an active ingredient | |
| IL174392A0 (en) | Stable lansoprazole formulation | |
| SI1608362T1 (sl) | Stabiliziran farmacevtski izdelek z amorfno aktivno učinkovino | |
| PL376465A1 (pl) | Kompozycja zawierająca mieszaninę składników czynnych oraz sposób jej otrzymywania | |
| PL370452A1 (pl) | Preparat w postaci stałego roztworu słabo rozpuszczalnej w wodzie substancji aktywnej | |
| AU2003276054A1 (en) | Method for the production of powdered active substance formulations by means of compressible fluids | |
| EP1590144A4 (en) | PROCESS FOR THE PREPARATION OF BIOLOGICALLY ACTIVE FORMULATIONS | |
| IL164280A0 (en) | Low foaming formulation of glyphosate | |
| PL2083007T3 (pl) | Sole tiotropium, sposoby ich wytwarzania oraz zawierające je kompozycje farmaceutyczne | |
| GB0307450D0 (en) | Method for interfacing storage devices | |
| GB2412338B (en) | Surface preparation of an implant | |
| EP1478396A4 (en) | PROCESS FOR PREPARING A PHARMACEUTICAL COMPOSITION | |
| AU2003224467A1 (en) | Process for the preparing of hardcapsule formulation containing lansoprazole | |
| HRP20040889A2 (en) | Hfa-suspension formulations containing an anticholinergic | |
| ZA200508282B (en) | Method of preparing a formulation containing a microdosed active principle | |
| GB0306088D0 (en) | Process for the preparation of a cosmetic active | |
| GB0314531D0 (en) | Process for the preparation of a cosmetic active | |
| IL176356A0 (en) | Effervescent preparation of a basic medical substance | |
| EP1669087A4 (en) | PREPARATION CONTAINING A BASIC MEDICINAL PRODUCT | |
| AU2003264443A8 (en) | Preparation for external use | |
| GB0306081D0 (en) | Process for the preparation of a cosmetic active | |
| GB0315617D0 (en) | Process for preparing a stable anthelmintic suspension formulation | |
| GB0605431D0 (en) | Method of preparing a LiNb1-xTaxO3 film | |
| HU0303383D0 (en) | Pellets containing active ingredient |